Cardiac involvement in MRI in young population after COVID-19: A single tertiary center experience.
Autor: | Erdol MA; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Ozbay MB; Cardiology Unit, Cubuk State Hospital, Ankara, Turkey., Yayla C; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Arslan H; Radiology Unit, Ankara Yildirim Beyazit University, Ankara, Turkey., Isiksalan Ozbulbul N; Radiology Unit, Ankara City Hospital, Ankara, Turkey., Ozcan Cetin EH; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Karanfil M; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Erdoğan M; Cardiology Unit, Ankara Yildirim Beyazit University, Ankara, Turkey., Demirtas K; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Ertem AG; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey., Akcay AB; Cardiology Unit, University of Health Sciences, Ankara City Hospital, Ankara, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2021 Aug; Vol. 38 (8), pp. 1327-1335. Date of Electronic Publication: 2021 Jul 19. |
DOI: | 10.1111/echo.15160 |
Abstrakt: | Background: Coronavirus 2019 (COVID-19) causes morbidity and mortality in an increasing number of people worldwide. Although it mainly affects the respiratory system, it influences all organs, including the heart. It is associated with a broad spectrum of widespread cardiovascular problems ranging from mild myocardial injury to fulminant myocarditis. We aimed to evaluate the presence and prevalence of cardiac involvement in asymptomatic or symptomatic patients after they recovered from COVID 19 infection. Methods: A total of 100 consecutive patients with COVID-19 proven by reverse transcription polymerase chain reaction (RT-PCR), under 40 years of age and without any known additional chronic diseases were analyzed retrospectively for cardiac magnetic resonance (CMR) results and symptoms. Results: Cardiac involvement was detected in 49 out of 100 patients on CMR imaging. In the cardiac involvement group, the number of patients with chest pain and/or dyspnea was 41 (84%), which was statistically significant (p = 0.001). Twenty-four patients (47%) in the without cardiac involvement group were asymptomatic and this was also statistically significant (p = 0.001). LV ejection fraction was statistically significantly lower in the group with cardiac involvement (61% vs 66%, p = 0.001). LV stroke volume and tricuspid annular plane systolic excursion (TAPSE) were statistically significantly lower in patients with cardiac involvement (p = 0.028 and p = 0.019, respectively). Conclusion: Based on single center experience, myocardial involvement is common in symptomatic patients after COVID-19. More studies are needed for long-term side effects and clinical results in these patients. (© 2021 Wiley Periodicals LLC.) |
Databáze: | MEDLINE |
Externí odkaz: |